100 – 8900 Glenlyon Parkway
Member Sector: Biopharmaceuticals
Tekmira Pharmaceuticals Corporation (http://www.tekmirapharm.com) is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs.
Tekmira is traded on both the Toronto and NASDAQ stock exchanges under the symbols TSX:TKM and NASDAQ:TKMR.
For the latest news from Tekmira, please visit their webpage at: